{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:21:13Z","timestamp":1776867673704,"version":"3.51.2"},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Safety"],"published-print":{"date-parts":[[1997,7]]},"DOI":"10.2165\/00002018-199717010-00002","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T00:09:16Z","timestamp":1236211756000},"page":"8-36","source":"Crossref","is-referenced-by-count":23,"title":["Adverse Effects of Class I Antiarrhythmic Drugs"],"prefix":"10.2165","volume":"17","author":[{"given":"Jacques","family":"Caron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Libersa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Drug Safety"],"original-title":[],"language":"en","deposited":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T14:13:57Z","timestamp":1455027237000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00002018-199717010-00002"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":0,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.2165\/00002018-199717010-00002","relation":{},"ISSN":["0114-5916"],"issn-type":[{"value":"0114-5916","type":"print"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}